9. SACCHARIN AND FOOD SAFETY STUDY SECTIONS 2 AND 3 OF THE SACCHARIN STUDY AND LABELING ACT [Public Law 95-203] SEC. 2. (a)(1) The Secretary of Health, Education, and Welfare (hereinafter in this Act referred to as the "Secretary") shall arrange, in accordance with subsection (b), for the conduct of based on available information, of— study, (A) current technical capabilities to predict the direct or secondary carcinogenicity or other toxicity in humans of substances which are added to, become a part of, or naturally occur in, food and which have been found to cause cancer in animals; (B) the direct and indirect health benefits and risks to individuals from foods which contain carcinogenic or other toxic substances; (C) the existing means of evaluating the risks to health from the carcinogenicity or other toxcity of such substances, the existing means of evaluating the health benefits of foods containing such substances, and the existing statutory authority for, and appropriateness of, weighing such risks against such benefits; (D) instances in which requirements to restrict or prohibit the use of such substances do not accord with the relationship between such risks and benefits; and (E) the relationship between existing Federal food regulatory policy and existing Federal regulatory policy applicable to carcinogenic and other toxic substances used as other than foods. (2) The Secretary shall arrange, in accordance with subsection (b), for the conduct of a study to determine, to the extent feasible(A) the chemical identity of any impurities contained in commercially used saccharin. (B) the toxicity or potential toxicity of any such impurities, including their carcinogenicity or potential carcinogenicity in humans, and (C) the health benefits, if any, to humans resulting from the use of nonnutritive sweeteners in general and saccharin in particular. (b)(1) The Secretary shall first request the National Academy of Sciences (hereinafter in this section referred to as the "Academy"), acting through appropriate units, to conduct the studies, required by subsection (a), under an arrangement whereby the actual expenses incurred by the Academy directly related to the conduct of such studies will be paid by the Secretary. If the Academy agrees to such request, the Secretary shall enter into such an agreement with the Academy. (2) If the Academy declines the Secretary's request to conduct any such study under such an arrangement, then the Secretary shall enter into a similar arrangement with another appropriate public or nonprofit private entity to conduct such study. (3) Any arrangement entered into under paragraph (1) or (2) of this subsection for the conduct of a study shall require that such study be completed and report thereon be submitted within such period as the Secretary may require to meet the requirements of subsection (c). (c)(1) Within 12 months of the date of the enactment of this Act the Secretary shall report to the Committee on Human Resources of the Senate and the Committee on Interstate and Foreign Commerce of the House of Representatives (A) the results of the study conducted pursuant to subsection (a)(2) (including supporting data and other materials provided by the entity which conducted the study), and (B) any action proposed to be taken on the basis of the results of the study. (2) Within 15 months of the date of the enactment of this Act the Secretary shall report to the Committee on Human Resources of the Senate and the Committee on Interstate and Foreign Commerce of the House of Representatives (A) the results of the studies (including supporting data and other materials provided by the entity which conducted the study) conducted pursuant to subsection (a)(1), (B) the recommendations, if any, of such entity for legislative and administrative action, and (C) such recommendations for legislative action as the Secretary deems necessary. (d) For purposes of this section and section 3, the term "saccharin" includes calcium saccharin, sodium saccharin, and ammonium saccharin. SEC. 3. During the period beginning on the date of the enactment of this Act and ending twenty-four months after the date of enactment of the Saccharin Study and Labeling Act Amendment of 1983, the Secretary (1) may not amend or revoke the interim food additive regulation of the Food and Drug Administration of the Department of Health, Education, and Welfare applicable to saccharin and published on March 15, 1977 (section 180.37 of part 180, subchapter B, chapter 1, title 21, Code of Federal Regulations (42 Fed. Reg. 14638)), or (2) may, except as provided in section 4 and the amendments made by such section, not take any other action under the Federal Food, Drug, and Cosmetic Act to prohibit or restrict the sale or distribution of saccharin, any food permitted by such interim food additive regulation to contain saccharin, or any drug or cosmetic containing saccharin, solely on the basis of the carcinogenic or other toxic effect of saccharin as determined by any study made available to the Secretary before the date of the enactment of this Act which involved human studies or animal testing, or both. 10. SINGLE CONVENTION ON NARCOTIC DRUGS, 1961, as amended by the 1972 Protocol Amending the Single Convention including Schedules; Final Acts and Resolutions as agreed by the 1961 United Nations Conference for the Adoption of a Single Convention on Narcotic Drugs and by the 1972 United Nations Conference to Consider Amendments to the Single Convention on Narcotic Drugs, 1961, respectively UNITED NATIONS New York, 1977 CONTENTS Page FINAL ACT OF THE UNITED NATIONS CONFERENCE FOR THE ADOPTION OF A SINGLE CONVENTION ON NARCOTIC DRUGS 1. The Economic and Social Council of the United Nations, by resolution 689 J (XXVI) of 28 July 1958, decided to convene in accordance with Article 62, paragraph 4, of the Charter of the United Nations, and with the provisions of General Assembly resolution 366 (IV) of 3 December 1949, a plenipotentiary conference for the adoption of a single convention on narcotic drugs to replace by a single instrument the existing multilateral treaties in the field, to reduce the number of international treaty organs exclusively concerned with control of narcotic drugs, and to make provision for the control of the production of raw materials of narcotic drugs. 2. The United Nations Conference for the Adoption of a Single Convention on Narcotic Drugs met at United Nations Headquarters from 24 January to 25 March 1961. 3. The following seventy-three States were represented by representatives at the Conference: |